Analyst Ratings for Cidara Therapeutics (CDTX)
CDTX Rating Summary
CDTX Price Target Summary
- Highest: $221.50 (RBC Capital)
- Lowest: $123.00 (WBB Securities)
- Average: $192.10
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$192.10 (-13.2%)
* Over Last 12-Mos
Rating Score: 6.8 / 10
Percentile Rank: 74%
Avg. $ Target:
$192.10 (-13.2%)
* Over Last 12-Mos
Rating Score: 6.8 / 10
Percentile Rank: 74%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/17/2025 | Guggenheim | Seamus Fernandez | Downgrade | Neutral (Buy) |
N/A (N/A) |
217.71 (221.38) |
1.69% | Details |
| 11/17/2025 | JPMorgan | Anupam Rama | Downgrade | Neutral (Overweight) |
221.50 (200.00) |
105.99 (221.38) |
108.87% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
